Human FcεRIa-specific human single-chain Fv (scFv) antibody with antagonistic activity toward IgE/FcεRIα-binding

被引:22
作者
Hashiguchi, S
Nakashima, T
Nitani, A
Yoshihara, T
Yoshinaga, K
Ito, Y
Maeda, Y
Sugimura, K
机构
[1] Kagoshima Univ, Fac Engn, Dept Bioengn, Kagoshima 8900065, Japan
[2] Chemo Sero Therapeut Res Inst, Kumamoto 8691298, Japan
[3] Kagoshima Univ, Hlth Serv Ctr, Kagoshima 8908580, Japan
关键词
allergy; Fc epsilon RI; human; phage antibody library; single-chain variable fragment; scFv;
D O I
10.1093/jb/mvg001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The alpha-chain of FcepsilonRI (FcepsilonRIalpha) plays a critical role in the binding of IgE to FcepsilonRI. A fully human antibody interfering with this interaction may be useful for the prevention of IgE-mediated allergic diseases. Here, we describe the successful isolation of a human single-chain Fv antibody specific to human FcepsilonRIalpha using human antibody phage display libraries. Using the non-immune phage antibody libraries constructed from peripheral blood lymphocyte cDNA from 20 healthy subjects, we isolated three phage clones (designated as FcRepsilon27, FcRepsilon51, and FcRepsilon70) through two rounds of bio-panning selection. The purified soluble scFv, FeRepsilon51, inhibited the binding of IgE to recombinant FcepsilonRIalpha, although both FcRepsilon27 and FcRepsilon70 showed fine binding specificity to FcepsilonRIalpha. Since FcRepsilon51 was determined to be a monomer by HPLC, BIAcore analysis was performed. The dissociation constant of FcRepsilon51 to FcepsilonRIalpha was estimated to be 20 nM, i.e., fortyfold lower than that of IgE binding to FcepsilonRIalpha (K-d = 0.5 nM). With these characteristics, FcRepsilon51 exhibited inhibitory activity on the release of histamine from passively sensitized human peripheral blood mononuclear cells.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 32 条
[1]   Regulation of mast cell survival by IgE [J].
Asai, K ;
Kitaura, J ;
Kawakami, Y ;
Yamagata, N ;
Tsai, M ;
Carbone, DP ;
Liu, FT ;
Galli, SJ ;
Kawakami, T .
IMMUNITY, 2001, 14 (06) :791-800
[2]  
BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190
[3]   Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis [J].
Casale, TB ;
Bernstein, IL ;
Busse, WW ;
LaForce, CF ;
Tinkelman, DG ;
Stoltz, RR ;
Dockhorn, RJ ;
Reimann, J ;
Su, JQ ;
Fick, RB ;
Adelman, DC .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (01) :110-121
[4]   Anti-immunoglobulin E (omalizumab) therapy in seasonal allergic rhinitis [J].
Casale, TB .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (08) :S18-S21
[5]   Effect of omalizumab on symptoms of seasonal allergic rhinitis - A randomized controlled trial [J].
Casale, TB ;
Condemi, J ;
LaForce, C ;
Nayak, A ;
Rowe, M ;
Watrous, M ;
McAlary, M ;
Fowler-Taylor, A ;
Racine, M ;
Gupta, N ;
Fick, R ;
Della Cioppa, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (23) :2956-2967
[6]  
DAVIS FM, 1993, SPRINGER SEMIN IMMUN, V15, P51
[7]   Peptide mimics of the CTLA4-binding domain stimulate T-cell proliferation [J].
Fukumoto, T ;
Torigoe, N ;
Kawabata, S ;
Murakami, M ;
Uede, T ;
Nishi, T ;
Ito, Y ;
Sugimura, K .
NATURE BIOTECHNOLOGY, 1998, 16 (03) :267-270
[8]   HUMAN ANTI-SELF ANTIBODIES WITH HIGH SPECIFICITY FROM PHAGE DISPLAY LIBRARIES [J].
GRIFFITHS, AD ;
MALMQVIST, M ;
MARKS, JD ;
BYE, JM ;
EMBLETON, MJ ;
MCCAFFERTY, J ;
BAIER, M ;
HOLLIGER, KP ;
GORICK, BD ;
HUGHESJONES, NC ;
HOOGENBOOM, HR ;
WINTER, G .
EMBO JOURNAL, 1993, 12 (02) :725-734
[9]  
HAAKFRENDSCHO M, 1994, IMMUNOLOGY, V82, P306
[10]   BIOLOGIC FUNCTION OF FC FRAGMENTS OF E-MYELOMA PROTEIN [J].
ISHIZAKA, K ;
ISHIZAKA, T ;
LEE, EH .
IMMUNOCHEMISTRY, 1970, 7 (08) :687-+